Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

CEO

James Frakes

Employees

Country

United States

ISIN

US00808Y4061

WKN

000A3EW0P

Listings

0 Comments

Share your thoughts

FAQ

What is Aethlon Medical stock price today?▼

The current price of EJU0.F is €0.55 EUR — it has decreased by -4.35% in the past 24 hours. Watch Aethlon Medical stock price performance more closely on the chart.

What is Aethlon Medical stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Aethlon Medical stocks are traded under the ticker EJU0.F.

What is Aethlon Medical revenue for the last year?▼

Aethlon Medical revenue for the last year amounts to 0 EUR.

What is Aethlon Medical net income for the last year?▼

EJU0.F net income for the last year is -11.25M EUR.

How many employees does Aethlon Medical have?▼

As of September 04, 2026, the company has 9 employees.

In which sector is Aethlon Medical located?▼

Aethlon Medical operates in the Health & Wellness sector.

When did Aethlon Medical complete a stock split?▼

The last stock split for Aethlon Medical was on October 05, 2023 with a ratio of 1:10.

Where is Aethlon Medical headquartered?▼

Aethlon Medical is headquartered in SAN DIEGO, United States.